Singapore markets closed

ENDRA Life Sciences Inc. (NDRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.0971-0.0059 (-5.73%)
At close: 04:00PM EDT
0.0993 +0.00 (+2.27%)
Pre-market: 05:58AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-12,994
-10,060
-13,179
-11,231
-11,726
-
Depreciation & amortisation
220.159
275.451
234.258
224.415
165.249
-
Stock-based compensation
1,321
996.43
1,200
1,445
2,102
-
Change in working capital
-890.123
-923.319
-1,026
-1,261
-1,521
-
Accounts receivable
-
-
-
-
-
0
Inventory
-1,134
-116.193
-1,360
-694.958
-476.178
-
Other working capital
-12,497
-9,583
-12,972
-11,167
-10,822
-
Other non-cash items
-
-
-
-
232.426
3,755
Net cash provided by operating activities
-12,333
-9,549
-12,769
-11,122
-10,747
-
Cash flows from investing activities
Investments in property, plant and equipment
-164.014
-33.884
-202.577
-45
-75.333
-
Net cash used for investing activities
-164.014
-24.721
-202.577
-45
-75.333
-
Cash flows from financing activities
Common stock issued
8,721
6,483
8,400
10,616
6,781
-
Net cash used provided by (used for) financing activities
8,721
7,518
8,400
13,402
11,875
-
Net change in cash
-3,777
-2,055
-4,572
2,234
1,053
-
Cash at beginning of period
11,793
4,889
9,462
7,227
6,174
-
Cash at end of period
8,016
2,834
4,889
9,462
7,227
-
Free cash flow
Operating cash flow
-12,333
-9,549
-12,769
-11,122
-10,747
-
Capital expenditure
-164.014
-33.884
-202.577
-45
-75.333
-
Free cash flow
-12,497
-9,583
-12,972
-11,167
-10,822
-